EXPIRED
Department
of Health and Human Services
Participating
Organizations
National Institutes of Health (NIH) http://www.nih.gov
Centers for Disease Control and Prevention (CDC) http://www.cdc.gov
Components
of Participating Organizations
Office of Behavioral and Social
Sciences Research (OBSSR)
http://obssr.od.nih.gov
National Cancer Institute (NCI)
http://www.nci.nih.gov/
National Center for Complementary and Alternative
Medicine (NCCAM) http://nccam.nih.gov/
National Eye Institute (NEI)
http://www.nei.nih.gov/
National Heart, Lung, and Blood Institute (NHLBI) http://www.nhlbi.nih.gov/index.htm
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) http://www.niams.nih.gov
National Institute of Allergy and Infectious Diseases
(NIAID) http://www.niaid.nih.gov
National Institute of Child Health and Human Development (NICHD) http://www.nichd.nih.gov/
National Institute of Dental and Craniofacial Research
(NIDCR) http://www.nidcr.nih.gov
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) http://www.niddk.nih.gov/
National Institute of Environmental Health Sciences (NIEHS) http://www.niehs.nih.gov
National Institute of General Medical Sciences (NIGMS) http://www.nigms.nih.gov/
National Institute of Mental Health (NIMH) http://www.nimh.nih.gov
National Institute of Neurological Disorders and Stroke (NINDS) http://www.ninds.nih.gov
National Institute of Nursing Research (NINR) http://www.ninr.nih.gov
National Institute on Aging (NIA) http://www.nia.nih.gov
National Institute on Alcohol Abuse and Alcoholism (NIAAA) http://www.niaaa.nih.gov/
National Institute on Deafness
and Communication Disorders (NIDCD) http://www.nidcd.nih.gov/
National Institute on Drug Abuse (NIDA) http://www.nida.nih.gov
National Library of Medicine (NLM)
http://www.nlm.nih.gov/
Office of Public Health Research
(OPHR/CDC) http://www.cdc.gov/od/science/PHResearch/
Title: Behavioral and Social Science Research on Understanding and Reducing Health Disparities (R01)
Announcement Type
New
Update: The following update relating to this announcement has been issued:
NOTICE: Applications submitted in response to this Funding Opportunity Announcement (FOA) for Federal assistance must be submitted electronically through Grants.gov (http://www.grants.gov) using the SF424 Research and Related (R&R) forms and the SF424 (R&R) Application Guide
APPLICATIONS MAY NOT BE SUBMITTED IN PAPER FORMAT.
This FOA must be read in conjunction with the application guidelines included with this announcement in Grants.gov/Apply for Grants (hereafter called Grants.gov/Apply).
A registration process is necessary before submission and applicants are highly encouraged to start the process at least four weeks prior to the grant submission date. See Section IV.
Program Announcement (PA) Number: PAR-07-379
Catalog of Federal
Domestic Assistance Number(s)
93.213,
93.393, 39.394, 93.395, 93.399, 93.867, 93.837,
93.866, 93.273, 93.856,
93.846, 93.865, 93.279, 93.173, 93.113, 93.859, 93.242, 93.853,93.361,93.879,
93.847, 93.848, 93.849, 93.121, 93.061
Key Dates
Release/Posted Date: June 7, 2007
Opening Date: July 19, 2007 (Earliest date an application may
be submitted to Grants.gov)
Letters
of Intent Receipt Date(s): August 20, 2007, August 20, 2008, August 20, 2009
NOTE: On time submission requires that applications be successfully
submitted to Grants.gov no later than 5:00 p.m. local time (of the applicant
institution/organization).
Application Submission/Receipt
Date(s): September 19, 2007, September 19, 2008,
September 18, 2009
Peer Review
Date(s): February-March of 2008, 2009, and
2010
Council Review Date(s): May 2008, May 2009, May 2010
Earliest
Anticipated Start Date(s): July 1,
2008, July 1, 2009, July 1, 2010
Additional Information To Be Available Date
(Activation Date): Not Applicable
Expiration
Date: September 19, 2009
Due Dates for E.O. 12372
Not
Applicable
Additional
Overview Content
Executive Summary
Table of Contents
Part I Overview Information
Part II Full Text of Announcement
Section I. Funding Opportunity
Description
1. Research Objectives
Section II. Award Information
1. Mechanism of Support
2. Funds Available
Section III. Eligibility Information
1. Eligible Applicants
A. Eligible Institutions
B. Eligible Individuals
2. Cost Sharing or Matching
3. Other-Special Eligibility Criteria
Section IV. Application and
Submission Information
1. Request Application Information
2. Content and Form of Application Submission
3. Submission Dates and Times
A. Submission, Review, and Anticipated Start Dates
1. Letter of Intent
B. Submitting an Application Electronically to the
NIH
C. Application Processing
4. Intergovernmental Review
5. Funding Restrictions
6. Other Submission Requirements
Section V. Application Review Information
1. Criteria
2. Review and Selection Process
A. Additional Review Criteria
B. Additional Review Considerations
C. Sharing Research Data
D. Sharing Research Resources
3. Anticipated Announcement and Award Dates
Section VI. Award Administration
Information
1. Award Notices
2. Administrative and National Policy Requirements
3. Reporting
Section VII. Agency Contacts
1. Scientific/Research Contact(s)
2. Peer Review Contact(s)
3. Financial/Grants Management Contact(s)
Section VIII. Other Information
- Required Federal Citations
Part II - Full Text of Announcement
Section I. Funding Opportunity Description
1. Research Objectives
The National Institutes of Health (NIH) issues this Funding Opportunity Announcement (FOA) to solicit research project grant applications (R01) employing behavioral and social science theories, concepts, and methods (1) to improve understanding of the causes of disparities in health and disability among the various populations of the United States and (2) to develop and test more effective interventions for reducing and eventually eliminating health disparities. The goal is to move beyond documenting the existence of health and disability disparities to addressing causes and solutions.
Definition of Health Disparities
Different public and private agencies have various definitions of a health disparity for their own program-related purposes, but these definitions tend to have several things in common. In general, health disparities are defined as significant differences between one population and another. (See Office of Minority Health, U.S. Department of Health and Human Services, http://www.omhrc.gov/templates/content.aspx?ID=3559.) The Minority Health and Health Disparities Research and Education Act of 2000, which authorizes several HHS programs, describes these disparities as differences in " the overall rate of disease [or disability] incidence, prevalence, morbidity, mortality or survival rates as compared to the health status of the general population." Although many different populations experience health disparities, this FOA is restricted to health disparities among populations defined by socioeconomic status, race/ethnicity, and/or rural-urban residence.
Fuller Understandings of Causes and Implications for Solutions
Scientific research supported by the National Institutes of Health (NIH) has been of great benefit to the health of the population in the United States. Research to improve diagnosis, treatment, and prevention has led to improvements in health care for most Americans, and significant declines in disability, morbidity, and mortality from numerous diseases and conditions. As a result, the population can expect not only to live longer, but to be more productive and to enjoy a higher quality of life. However, these gains have not affected all segments of the population equally. A few examples of persistent health disparities are:
In sum, US populations defined by lower socioeconomic status, certain racial/ethnic backgrounds, and rural residence continue to experience substantial disparities in the burden of disease and death when compared to the US population as a whole or to European Americans.
The research opportunities identified in this announcement are the result of discussions between the extramural research community and the NIH Behavioral and Social Sciences Research Coordinating Committee as well as at the NIH Conference on Understanding and Reducing Disparities in Health: Behavioral and Social Sciences Research Contributions (October 23-24, 2006). This announcement highlights important areas for investigation that may not be included in the health-disparities strategic plans of individual NIH Institutes or Centers. (See Strategic Research Plan and Budget to Reduce and Ultimately Eliminate Health Disparities, FY 2002-2006, http://ncmhd.nih.gov/our_programs/strategic/volumes.asp.)
Given the extensive scientific literature documenting health disparities, this announcement calls for research to improve and elaborate explanations and understandings of the causes for health disparities. In so doing, the announcement stresses the explicit employment of concepts and models from the behavioral and social sciences to guide basic and applied research by focusing on three action areas: Public Policy, Health Care, and Disease/disability prevention. (See below.) It emphasizes (1) basic research on the behavioral and social acting with or through biological pathways that give rise to disparities in health and (2) applied or translational research on the development, testing, and delivery of interventions to reduce disparities. It encourages a multi-level analytic framework (i.e., ranging from individuals to societies) in investigating public health issues and their interactions (e.g., multiple morbidities rather than single illnesses) as well as attention to risk factors or causal processes common to various health conditions (e.g., smoking, diet, exercise, and access to health care).
Moreover, this announcement encourages research on the causes of and solutions to the health differences between a focus-population group and a reference-population group (e.g., African Americans vs. European Americans or the US population as a whole). By definition, health disparities refer to the health of a group in comparison to the health of other groups. Although improving the absolute level of a population group’s health is a laudable goal, it may not result in changing the group’s relative level of health: The reference population’s health might also improve, thereby maintaining or even widening the gap. The study of a single population group (in order to elucidate the circumstances that may contribute to health disparities or to test an intervention targeting a particular group) may be included under this announcement. However, the relevance to disparities must be addressed explicitly. Also of interest is research on the causes of disparities within a single population group (e.g., among African Americans).
Areas of Action Affecting Health Disparities
This Funding Opportunities Announcement focuses on three broad areas of action influencing health disparities: Public Policy, Healthcare, and Disease/disability prevention. For the purposes of this FOA, these action areas are defined as:
PUBLIC POLICY: Public policy may be defined as the means employed by governments and other institutions to influence the function and well-being of individuals, groups, communities, and society as a whole. Some public policies at the national, state, and local levels are designed explicitly to affect health and may have direct impacts on health disparities. Examples include medical insurance programs for the elderly, disabled, and poor; alterations in health programs to contain costs; occupational safety regulations; and regulation of environmental hazards.
In addition, policies with no explicit health focus may also affect health and health disparities indirectly. For example, laws prohibiting discriminatory housing practices or housing subsidies may reduce health disparities by ameliorating exposures to environmental toxins among poor and ethnic/racial populations. The provision of child-care centers in workplaces may increase breastfeeding. Income maintenance programs may help to reduce stress and improve diets. Whereas such effects are plausible given known pathways linking socioeconomic disadvantage and racial/ethnic status to health, research evidence documenting their existence and strength is largely lacking.
Public and private sector policies are an important and modifiable element of the complex social environmental system that contributes to health disparities. Although scientific knowledge is rarely the only factor driving the formation of policies, rigorous and objective scientific studies can help to inform policy making by providing data on which to base assumptions about the costs and benefits and likely effects of various policy options.
Advancing knowledge about the potential for reducing health disparities through policy mechanisms requires a broad set of research studies, including both basic and intervention research. Further, interdisciplinary efforts are needed to bridge the many different kinds of economic, social, behavioral, and biological processes involved in translating public policy into public health. Examples include research on:
HEALTH CARE: Health-care is defined as the timely delivery of care and/or medical services by general or specialty providers to persons in need for the purpose of diagnosis, assessment, or treatment in order to improve or protect health status. Differences in the quantity and quality of health care targeted to and received by members of population groups are critical to understanding disparities in health.
For example, members of certain racial/ethnic groups are less likely than the general population to receive health-care services. For example, blacks are less likely than whites to receive common diagnostic procedures and treatments or to receive intensive interventions such as by-pass surgery. Furthermore, racial disparities exist in important qualitative aspects of medical care, e.g., receiving care from a private physician vs. hospital outpatient or emergency departments.
Increased conceptual and empirical efforts are needed to identify and understand the processes leading to differentials in health care and to develop intervention strategies. Note that merely documenting or comparing utilization rates is not in the purview of this FOA. Explanatory analyses of the origins of differential rates or evidence-based interventions to improve rates are the focus of this FOA.
Disparities in the quantity and quality of health care may result from the interaction of several factors. Among these are:
DISEASE/DISABILITY PREVENTION: Prevention research encompasses investigations designed to yield results directly applicable to identifying and assessing risk, and to developing interventions for preventing or ameliorating high-risk behaviors, the occurrence of disease/disorder/injury or progression of detectable but asymptomatic disease. Prevention research also includes research studies to develop and evaluate disease/disability prevention and health promotion recommendations and public health programs. Included is research on:
While several interventions to improve health-enhancing behaviors in the areas of smoking, drinking, physical activity, and diet have been developed, most previous research has targeted easy-to-reach populations. The effectiveness of these interventions for vulnerable populations in diverse population groups is still undetermined. Although a variety of theoretical models (health belief model, theory of reasoned action, trans-theoretical model and stages of change, etc.) have been developed to describe the process of health behavior change, still unknown is the relevance of different theories for changing particular behaviors in various populations. In addition to research on individual level behavior change, gaps remain in the development and testing of community level interventions for a diversity of communities experiencing health disparities. Also needed is research on personal, cultural, and institutional barriers to intervention availability, delivery and effectiveness as a function of population-group membership, as well as the mechanisms of intervention that work best to prevent disease in population groups experiencing health disparities.
CROSSING BOUNDARIES. The boundaries between these three broad topics are arbitrary and permeable. For example, policy is often directed explicitly at health care or prevention. Similarly, how health care is provided influences prevention (and vice versa). These categories are provided as heuristics for organizing topics. Consequently, the NIH encourages research on topics falling within more than one of these categories or on the interplay among the categories.
Research Perspectives and Themes
To achieve the twin goals of a more comprehensive understanding of the causes of health disparities and to design and implement effective interventions to reduce and ultimately eliminate health disparities, this FOA encourages the application of several research perspectives and themes. The NIH believes these approaches may move current research efforts to the next level of accomplishment. Applicants are not required to incorporate all of these themes into their research proposals.
Interdisciplinary collaborations. Addressing health disparities requires a greater understanding of the full range of factors that determine health - biological, medical, behavioral, social, and environmental and of their complex interrelationships. In many instances, a single research discipline is best suited to tackle specific health problems. However, it is increasingly recognized that particular problems cannot be adequately addressed within a single discipline, and instead require a more comprehensive approach. New discoveries and innovative solutions may become possible when researchers in different disciplines meet at the interfaces and frontiers of those disciplines to pool their diverse knowledge. Interdisciplinary collaborations refer to scientific endeavors in which a variety of disciplines work together closely from the outset to form a shared conceptual framework to address a problem. Interdisciplinary research is distinct from multidisciplinary research in that the latter refers to a process in which researchers in different disciplines work relatively independently, each from his or her own disciplinary perspective with limited direct interaction and little cross-fertilization among disciplines. The NIH encourages interdisciplinary studies that cross the traditional boundaries within and between biological, behavioral, and social sciences.
Levels of analyses. A variety of scientists have offered the concept of levels of analysis to capture the distinct but interdependent levels at which health, and the determinants of health, can be understood. (See http://grants.nih.gov/grants/guide/pa-files/PA-05-029.html.) One schema identifies five major levels of analysis in health research: social/environmental, behavioral/psychological, organ systems, cellular, and molecular. Most research focuses on a specific level, which roughly corresponds to the domain of specific scientific disciplines. However, while the disciplines concerned with health research may be separated conceptually, methodologically, and administratively, the processes about which they are concerned are inextricably linked. A levels-of-analysis approach offers a framework for understanding the interdependence among levels. A variety of conceptual models exist to address the linkages among levels of analysis, from the macro-societal levels to the biology of a disease, but they have not been uniformly accepted or systematically applied in empirical studies of health. One framework links social structure or social position (e.g., class, age, gender, race, ethnicity), environmental context or place (e.g., geographic location, housing conditions, access to services), lifestyles (e.g., smoking, physical activity), and physiology (e.g., blood pressure, cholesterol, obesity). Others suggest a metaphor of Chinese boxes to guide a new eco-epidemiology which treats relationships within and between localized structures that are bounded socially, biologically, or topographically . Such frameworks help to guide the development of multi-level research. They also illustrate how such research can inform public knowledge about health policy, organizational and community level interventions, and primary and secondary intervention. Thus, models that integrate, for example, factors operating at the social and cultural levels with those operating at the psychological and biological levels are especially encouraged. Many multi-level studies are also multi-method studies that integrate quantitative and qualitative data and thus strengthen measurement validity while retaining the capacity for statistical inference.
An accumulated body of empirical findings has clearly demonstrated that social and cultural factors create conditions of life that can protect or damage health. These conditions influence health by affecting such things as exposure and vulnerability to disease, risk-taking behaviors, the effectiveness of health promotion efforts, and access to, availability of, and quality of health care. They play a critical role in shaping individuals responses to health problems and influence how poor health affects indi viduals lives and well-being. The social sciences contribute to the nation’s health research agenda by addressing the dynamics of these social and cultural processes and the mechanisms through which they affect health.
A concern for health at the population rather than the individual level underscores the need to take social and cultural processes into account. An understanding of current and changing population rates of morbidity, survival, mortality, and use of health services requires that we consider the demographic, social, economic, and cultural features of the population. Needed is the investigation of the social, economic, and cultural systems as well as the individuals who participate in them.
Systems Science Methodologies. Systems thinking refers to bringing a perspective to problem-solving in which the problem space is conceptualized as a system of interrelated component parts. The system is viewed as a coherent whole. The relationships among the components are also recognized and seen as critical to the system, for they give rise to the emergent properties of the system. Emergent properties are those properties that can only be seen at the system level and are not attributes of the individual components themselves (e.g., a flock emerges when a group of birds flies together; it is a property of the system, not of any individual bird). Systems approaches offer insights into the nature of the whole system that often cannot be gained by studying the component parts in isolation. Moreover, a systems approach recognizes that embedded in the system are feedback loops, stocks and flows, that change over time (i.e., dynamic complexity of the system). Advantages of utilizing systems approaches as a complementary method for addressing complex problems include the fact that non-linear relationships, unintended effects of intervening in the system, and time-delayed effects are often missed with traditional reductionistic approaches, whereas systems approaches excel at detecting these.
Systems approaches are able to address a broad range of factors within a single framework from genetic to environmental, cellular to behavioral, and biological to social levels of analysis. Systems thinking is also logically related to knowledge and computing infrastructures necessary to link networks of researchers in their collaborative work. Successful application of these approaches in defense, business, and cellular biology have resulted in a growing interest in the use of systems approaches to population health research. The belief is that a systems approach shows promise for understanding and intervening on the complex, multi-dimensional relationships underlying health disparities.
A wide variety of methodologies are encompassed under systems science. Any variety is acceptable under this PAR. Here are some examples of the methodologies being sought under this PAR; note that this list is meant to be illustrative and not exhaustive:
Applicants are encouraged to learn more about systems methodologies and their role in behavioral and social science research at NIH by visiting the OBSSR Systems Science and Health webpage at http://obssr.od.nih.gov/Content/About_OBSSR/Activities/Systems_Science/.
Life-course perspective. Cumulative processes over the life course across multiple life domains at the individual and community levels are of central importance for understanding the associations between membership in socially-defined population groups and health. For example, racial/ethnic group status influences early life conditions, including the fetal environment, that may be linked with later life expectancy and disease risks. Consequently, integrated investigation of psychosocial and physiological interrelationships over the life course and at critical developmental transitions are required in order to more fully understand the contemporaneous and cumulative impact of differential life experiences that underlie health disparities. Specifically, normative transitions (e.g., birth of a child, beginning school, emerging adulthood, retirement) often represent periods of increased vulnerability to both mental and physical health problems, and as such offer unique opportunities for intervention. For example, the early adolescent period has been identified as one which involves a combination of biological (e.g., puberty), social (e.g., increased role of the peer group), ecological (e.g., middle school), and cognitive (e.g., increased capacity for abstract thinking) changes as well as increased risk for certain disorders such as depression. Yet, our understanding of the role of such developmental processes in the emergence, maintenance and potential alleviation of health disparities is limited. Thus, focusing attention on a wide variety of transitions across the lifespan along with the risk and protective factors related to them is needed for the ultimate development and testing of innovative interventions that target high risk periods across the life course. Such an approach emphasizes the fact that early life disadvantage and adversity need not lead to later negative outcomes, provided there are compensating positive experiences in the intervening years. Similarly, attention should be given to the positive aspects of people’s lives (e.g., positive social relationships and social support, education) that may buffer or compensate for the effects of adversity.
Community-based participatory research (CBPR). CBPR is defined as scientific inquiry conducted in communities and in partnership with researchers. The process of scientific inquiry is such that community members, persons affected by the health condition, disability or issue under study, or other key stakeholders in the community's health have the opportunity to be full participants in each phase of the work (e.g., from conception, design, conduct, analysis, interpretation, conclusions to communication of results). CBPR is characterized by substantial community input in the development of the grant application (http://www.niehs.nih.gov/translat/cbpr/cbpr.htm).
Community-partnered approaches to research promise to deepen our scientific base of knowledge in the areas of health promotion, disease/disability prevention, and health disparities. (See http://grants.nih.gov/grants/guide/pa-files/PAR-07-283.html.) Community-partnered research processes offer the potential to generate better-informed hypotheses, develop more effective interventions, and enhance the translation of the research results into practice.
Prejudice and discrimination. Disparities in health exist for many reasons, but prejudice and discrimination intentional and conscious as well as unintentional and unconscious on the basis of race, ethnicity, gender, social class, sexual orientation, etc. appear to contribute significantly to differences in health care. (Also see http://grants.nih.gov/grants/guide/pa-files/PA-07-206.html.) For example, a recent study of racial factors that contribute to differentials in diagnosis and treatment demonstrated that racial bias is a significant influence on the likelihood that cardiac catheterization will be recommended for patients with chest pain.
Bias, discrimination and prejudice are hypothesized to contribute to disparities in health through increased exposure and susceptibility to: 1) Economic and social deprivation; 2) toxic substances and hazardous conditions; 3) socially inflicted mental and physical trauma, either directly experienced or witnessed; 4) targeted marketing of potentially harmful commodities such as tobacco, alcohol, illicit drugs; and 5) inadequate or degrading medical care.
The influence of actual as well as perceived (e.g., stereotype threat ) prejudice and discrimination is not limited to access to health care. They can be sources of acute and chronic stress, which have been linked to conditions such as cardiovascular disease and alcohol abuse. Discrimination can restrict the educational, employment, economic, residential and partner choices of individuals, affecting health through pathways linked with what psychosocial scientists refer to as human or social capital. Environmental influences from industry, toxic waste disposal sites, and other geographic aspects linked with poverty and racial/ethnic status can result in serious disadvantages to a population groups' health.
Evidence is insufficient to evaluate the magnitude of the relationship among prejudice, discrimination, and health. In addition, much of the empirical work investigating the effects of prejudice and discrimination and health has focused on African Americans. Few studies have addressed systematically how prejudice and discrimination affect other racial/ethnic groups such as Native Americans, Asian Americans and Latinos or other socially-defined populations. Prejudice and discrimination have helped shape the social position of each racial and ethnic group in the U.S. and, consequently, they may have unique associations with health for each group. Finally, an insufficient focus on the impact of societal forces has hindered our ability to understand and effectively address the influence of prejudice and discrimination on health disparities. The growing evidence that health, socioeconomic status, and macro-economics are inextricably linked emphasizes the importance of undertaking a program of research to examine the relative magnitude of the influence of bias in the context of the other factors thought to affect racial/ethnic health.
Social context. The social environments in which processes affecting health and health disparities play out are often referred to as social context. These include familial, demographic, economic, political, legal, organizational, physical environmental, and cultural factors that affect the resources available to individuals throughout their life course. Applicants are encouraged to conceptualize and measure social contexts in order to specify which particular aspects of social context are factors in the production or maintenance of the health disparity under examination. They are also encouraged to conceptualize and measure the social processes that operate within and across social contexts and between social contexts and individuals.
Social context can be roughly divided into five inter-related domains: families and households; social networks; neighborhoods; formal institutions; and public policy. Economic, social, and cultural processes interweave all of these domains.
Examples of Research Topics
Several NIH components and the Centers for Disease Control and Prevention (CDC) have joined together to support this Funding Opportunity Announcement (FOA). Applications should be relevant to both the objectives of the FOA and to at least one of the participating organization's research interests. Researchers are strongly encouraged to review the general research interests of the participating organizations and the examples of topics of interest specific to health/disabilities disparities, which are posted at http://obssr.od.nih.gov/Content/Health_DisparitiesPAR_R01.htm.
See Section VIII, Other Information
- Required Federal Citations, for policies related
to this announcement.
Section
II. Award Information
1. Mechanism of Support
This Funding Opportunity Announcement (FOA) will use
the NIH Research Project Grant (R01) award mechanism.
The applicant will be solely responsible for planning, directing, and executing the proposed project.
This FOA uses Just-in-Time information concepts. It also uses the modular as well as the non-modular budget formats (see http://grants.nih.gov/grants/funding/modular/modular.htm). Specifically, if you are a U.S. organization and are submitting an application with direct costs in each year of $250,000 or less (excluding consortium Facilities and Administrative [F&A] costs), use the PHS398 Modular Budget component provided in the SF424 (R&R) Application Package and SF424 (R&R) Application Guide (see specifically Section 5.4, Modular Budget Component, of the Application Guide).
U.S. applicants requesting more than $250,000 in annual direct costs and all foreign applicants must complete and submit budget requests using the Research & Related Budget component found in the application package for this FOA. See NOT-OD-06-096, August 23, 2006.
At this time, it is not known if competing renewal (formerly competing continuation ) applications will be accepted and/or if this FOA will be reissued.
2. Funds Available
During the first year of this announcement, the NIH anticipates supporting 20 to 30 awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the numbers, quality, duration, and costs of the applications received. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made in response to this FOA.
Section III. Eligibility Information
1. Eligible Applicants
1.A. Eligible
Institutions
You may submit an application(s) if your
institution/organization has any of the following characteristics:
1.B. Eligible Individuals
Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the PD/PI is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.
More than one PD/PI, or multiple PDs/PIs, may be designated on the application for projects that require a team science approach that clearly does not fit the single-PD/PI model. Additional information on the implementation plans and policies and procedures to formally allow more than one PD/PI on individual research projects is available at http://grants.nih.gov/grants/multi_pi. All PDs/PIs must be registered in the NIH eRA Commons prior to the submission of the application (see http://era.nih.gov/ElectronicReceipt/preparing.htm for instructions).
The decision of whether to apply for a single PD/PI or multiple PD/PI grant is the responsibility of the investigators and applicant organizations and should be determined by the scientific goals of the project. Applications for multiple PD/PI grants will require additional information, as outlined in the instructions below. The NIH review criteria for approach, investigators, and environment have been modified to accommodate applications involving either a single PD/PI or multiple PDs/PIs. When considering multiple PDs/PIs, please be aware that the structure and governance of the PD/PI leadership team as well as the knowledge, skills and experience of the individual PD/PIs will be factored into the assessment of the overall scientific merit of the application. Multiple PDs/PIs on a project share the authority and responsibility for leading and directing the project, intellectually and logistically. Each PD/PI is responsible and accountable to the grantee organization, or, as appropriate, to a collaborating organization, for the proper conduct of the project or program, including the submission of required reports. For further information on multiple PDs/PIs, please see http://grants.nih.gov/grants/multi_pi.
2.
Cost Sharing or Matching
This program does not require cost sharing as defined in the current NIH
Grants Policy Statement.
3. Other-Special
Eligibility Criteria
At this time, it is not known if competing renewal (formerly competing continuation ) applications will be accepted and/or if this FOA will be reissued.
Section IV. Application and Submission Information
To download a SF424 (R&R) Application Package and
SF424 (R&R) Application Guide for completing the SF424 (R&R) forms for
this FOA, link to http://www.grants.gov/applicants/apply_for_grants.jsp and follow the directions provided on that Web site.
A one-time registration is required for institutions/organizations at both:
PDs/PIs should work with their institutions/organizations to make sure they are registered in the eRA Commons.
Several additional separate actions are required before an applicant institution/organization can submit an electronic application, as follows:
1) Organizational/Institutional Registration in Grants.gov/Get Registered
2) Organizational/Institutional Registration in the eRA Commons
3) Project Director/Principal Investigator (PD/PI) Registration in the NIH eRA Commons: Refer to the NIH eRA Commons System (COM) Users Guide.
Both the PD/PI(s) and AOR/SO need separate accounts in the NIH eRA Commons since both are authorized to view the application image.
Note that if a PD/PI is also an NIH peer-reviewer with an Individual DUNS and CCR registration, that particular DUNS number and CCR registration are for the individual reviewer only. These are different than any DUNS number and CCR registration used by an applicant organization. Individual DUNS and CCR registration should be used only for the purposes of personal reimbursement and should not be used on any grant applications submitted to the Federal Government.
Several of the steps of the registration process could take four weeks or more. Therefore, applicants should immediately check with their business official to determine whether their organization/institution is already registered in both Grants.gov and the Commons. The NIH will accept electronic applications only from organizations that have completed all necessary registrations.
1. Request Application Information
Applicants must download the SF424 (R&R)
application forms and the SF424 (R&R) Application Guide for this FOA
through Grants.gov/Apply.
Note: Only the forms package
directly attached to a specific FOA can be used. You will not be able to use
any other SF424 (R&R) forms (e.g., sample forms, forms from another FOA),
although some of the "Attachment" files may be useable for more than
one FOA.
For further assistance, contact GrantsInfo: Tel.:
301-710-0267, E-mail: GrantsInfo@nih.gov.
Telecommunications for the hearing impaired: TTY
301-451-5936.
2. Content and Form of Application Submission
Prepare all applications using the SF424 (R&R) application forms and in accordance with the SF424 (R&R) Application Guide for this FOA through Grants.gov/Apply.
The SF424 (R&R) Application Guide is critical to submitting a complete and accurate application to NIH. There are fields within the SF424 (R&R) application components that, although not marked as mandatory, are required by NIH (e.g., the Credential log-in field of the Research & Related Senior/Key Person Profile component must contain the PD/PI’s assigned eRA Commons User ID). Agency-specific instructions for such fields are clearly identified in the Application Guide. For additional information, see Frequently Asked Questions Application Guide, Electronic Submission of Grant Applications.
The SF424 (R&R) application has several components. Some components are required, others are optional. The forms package associated with this FOA in Grants.gov/APPLY includes all applicable components, required and optional. A completed application in response to this FOA includes the data in the following components:
Required Components:
SF424
(R&R) (Cover component)
Research & Related Project/Performance Site Locations
Research & Related Other Project Information
Research & Related Senior/Key Person
PHS398 Cover Page Supplement
PHS398 Research Plan
PHS398 Checklist
PHS398 Modular Budget or Research & Related
Budget, as appropriate (See Section IV.6., Special Instructions,
regarding appropriate required budget component.)
Research
& Related Budget (required for foreign applications)
Optional Components:
PHS398 Cover Letter File
Research & Related Subaward Budget Attachment(s) Form
Foreign Organizations (Non-domestic (non-U.S.) Entity)
NIH policies concerning grants to
foreign (non-U.S.) organizations can be found in the NIH Grants Policy Statement at: http://grants.nih.gov/grants/policy/nihgps_2003/NIHGPS_Part12.htm#_Toc54600260.
Applications from foreign organizations must:
Proposed research should provide special opportunities for furthering research programs through the use of unusual talent, resources, populations, or environmental conditions in other countries that are not readily available in the United States or that augment existing U.S. resources.
SPECIAL INSTRUCTIONS
Applications with Multiple PDs/PIs
When multiple PDs/PIs are proposed, NIH requires one PD/PI to be designated as the "Contact PI, who will be responsible for all communication between the PDs/PIs and the NIH, for assembling the application materials outlined below, and for coordinating progress reports for the project. The contact PD/PI must meet all eligibility requirements for PD/PI status in the same way as other PDs/PIs, but has no other special roles or responsibilities within the project team beyond those mentioned above.
Information for the Contact PD/PI should be entered in item 15 of the SF424 (R&R) Cover component. All other PDs/PIs should be listed in the Research & Related Senior/Key Person component and assigned the project role of PD/PI. Please remember that all PDs/PIs must be registered in the eRA Commons prior to application submission. The Commons ID of each PD/PI must be included in the Credential field of the Research & Related Senior/Key Person component. Failure to include this data field will cause the application to be rejected.
All projects proposing Multiple PDs/PIs will be required to include a new section describing the leadership of the project.
Multiple PD/PI Leadership Plan: For applications designating multiple PDs/PIs, a new section of the research plan, entitled Multiple PD/PI Leadership Plan (Section 14 of the Research Plan Component in the SF424 (R&R)), must be included. A rationale for choosing a multiple PD/PI approach should be described. The governance and organizational structure of the leadership team and the research project should be described, including communication plans, process for making decisions on scientific direction, and procedures for resolving conflicts. The roles and administrative, technical, and scientific responsibilities for the project or program should be delineated for the PDs/PIs and other collaborators.
If budget allocation is planned, the distribution of resources to specific components of the project or the individual PDs/PIs should be delineated in the Leadership Plan. In the event of an award, the requested allocations may be reflected in a footnote on the Notice of Award.
Applications Involving a Single Institution
When all PDs/PIs are within a single institution, follow the instructions contained in the SF424 (R&R) Application Guide.
Applications Involving Multiple Institutions
When multiple institutions are involved, one institution must be designated as the prime institution and funding for the other institution(s) must be requested via a subcontract to be administered by the prime institution. When submitting a detailed budget, the prime institution should submit its budget using the Research & Related Budget component. All other institutions should have their individual budgets attached separately to the Research & Related Subaward Budget Attachment(s) Form. See Section 4.8 of the SF424 (R&R) Application Guide for further instruction regarding the use of the subaward budget form.
When submitting a modular budget, the prime institution completes the PHS398 Modular Budget component only. Information concerning the consortium/subcontract budget is provided in the budget justification. Separate budgets for each consortium/subcontract grantee are not required when using the Modular budget format. See Section 5.4 of the Application Guide for further instruction regarding the use of the PHS398 Modular Budget component.
3.
Submission Dates and Times
See Section IV.3.A. for
details.
3.A.
Submission, Review, and Anticipated Start Dates
Opening Date: July 19, 2007 (Earliest
date an application may be submitted to Grants.gov).
Letters
of Intent Receipt Date(s): August 20, 2007, August 20, 2008, August 20, 2009
Application
Submission/Receipt Date(s): September 19 2007, September 19, 2008, September 18, 2009.
Peer Review
Date(s): February-March of 2008, 2009, and 2010
Council Review
Date(s): May 2008, May 2009, May 2010
Earliest
Anticipated Start Date(s): July 1,
2008, July 1, 2009, July 1, 2010
3.A.1. Letter of Intent
Prospective applicants are asked to submit a letter of intent that includes the following information:
Although
a letter of intent is not required, is not binding, and does not enter into the
review of a subsequent application, the information that it contains allows IC
staff to estimate the potential review workload and plan the review.
The letter of
intent is to be sent by the date listed in Section
IV.3.A.
The letter of
intent should be sent to:
Ronald P. Abeles, Ph.D.
Office
of Behavioral and Social Sciences Research
National Institutes of Health
31
Center Drive
Building 31, Room B1C19
Bethesda,
MD 20892-2027
Tel.:
301-496-7859
Fax:
301-435-8779
E-mail: abeles@nih.gov
3.B. Submitting an Application Electronically to the
NIH
To submit an application in response to this FOA, applicants should access this
FOA via http://www.grants.gov/applicants/apply_for_grants.jsp and follow steps 1-4. Note: Applications must only be submitted electronically.
PAPER APPLICATIONS WILL NOT BE ACCEPTED.
3.C.
Application Processing
Applications may be submitted on or
after the opening date and must be successfully received by Grants.gov
no later than 5:00 p.m. local time (of the applicant institution/organization) on the application submission/receipt date(s). (See Section IV.3.A. for all dates.) If an
application is not submitted by the receipt date(s) and time, the application
may be delayed in the review process or not reviewed.
Once an application package has been successfully submitted through Grants.gov, any errors have been addressed, and the assembled application has been created in the eRA Commons, the PD/PI and the Authorized Organization Representative/Signing Official (AOR/SO) have two business days to view the application image.
Upon receipt, applications will be evaluated for completeness by the CSR. Incomplete applications will not be reviewed
There will be an acknowledgement of receipt of applications from Grants.gov and the Commons. The submitting AOR receives the Grants.gov acknowledgments. The AOR and the PI receive Commons acknowledgments. Information related to the assignment of an application to a Scientific Review Group is also in the Commons.
Note: Since E-mail can be unreliable, it is the responsibility of the applicant to check periodically on their application status in the Commons.
The NIH will not accept any application in response to this FOA that is essentially the same as one currently pending initial merit review unless the applicant withdraws the pending application. The NIH will not accept any application that is essentially the same as one already reviewed. This does not preclude the submission of an application already reviewed with substantial changes, but such application must include an Introduction addressing the previous critique. Note such an application is considered a "resubmission" for the SF424 (R&R).
4. Intergovernmental Review
This initiative is not
subject to intergovernmental
review.
5.
Funding Restrictions
All NIH awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.
Pre-award costs are allowable. A grantee may, at its own risk and without NIH prior approval, incur obligations and expenditures to cover costs up to 90 days before the beginning date of the initial budget period of a new or competing renewal (formerly competing continuation ) award if such costs: are necessary to conduct the project, and would be allowable under the grant, if awarded, without NIH prior approval. If specific expenditures would otherwise require prior approval, the grantee must obtain NIH approval before incurring the cost. NIH prior approval is required for any costs to be incurred more than 90 days before the beginning date of the initial budget period of a new or competing renewal award.
The incurrence of pre-award costs in anticipation of a competing or non-competing award imposes no obligation on NIH either to make the award or to increase the amount of the approved budget if an award is made for less than the amount anticipated and is inadequate to cover the pre-award costs incurred. NIH expects the grantee to be fully aware that pre-award costs result in borrowing against future support and that such borrowing must not impair the grantee's ability to accomplish the project objectives in the approved time frame or in any way adversely affect the conduct of the project. See the NIH Grants Policy Statement.
6. Other Submission
Requirements
PD/PI Credential (e.g., Agency Login)
The NIH requires the PD/PI(s) to fill in his/her Commons User ID in the PROFILE Project Director/Principal Investigator section, Credential log-in field of the Research & Related Senior/Key Person Profile component.
Organizational DUNS
The applicant organization must include its DUNS number in its Organization Profile in the eRA Commons. This DUNS number must match the DUNS number provided at CCR registration with Grants.gov. For additional information, see Frequently Asked Questions Application Guide, Electronic Submission of Grant Applications.
PHS398 Research Plan Component Sections
Items 2-5 of the PHS398 Research Plan component are limited to 25 pages. While each section of the Research Plan component needs to be uploaded separately as a PDF attachment, applicants are encouraged to construct the Research Plan component as a single document, separating sections into distinct PDF attachments just before uploading the files. This approach will enable applicants to better monitor formatting requirements such as page limits. All attachments must be provided to NIH in PDF format, filenames must be included with no spaces or special characters, and a .pdf extension must be used.
All application instructions outlined in the SF424 (R&R) Application Guide are to be followed, incorporating "Just-in-Time" information concepts, and with the following additional requirements:
Special Instructions for Modular Grant applications
R01 applications from U.S. institutions/organizations requesting up to $250,000 per year in direct costs (excluding consortium F&A costs) must be submitted in a modular budget format. Additional information on modular budgets is available at http://grants.nih.gov/grants/funding/modular/modular.htm. When submitting a modular budget, the applicant organization will include only the PHS398 Modular Budget component. See Section 5.4 of the SF424 (R&R) Application Guide for further instructions regarding the use of the PHS398 Modular Budget component.
Foreign organizations may not submit modular budgets. See NOT-OD-06-096.
Special Instructions for Applications Requesting $500,000 (direct costs) or More Per Year
Applicants requesting $500,000 or
more in direct costs for any year (excluding consortium F&A costs) must
carry out the following steps:
1) Contact the IC program staff at least 6 weeks
before submitting the application, i.e., as you are developing plans for the
study;
2) Obtain agreement from the IC
staff that the IC will accept your application for consideration for award;
and,
3) Include the PHS398 Cover Letter
component with the application to identify the staff member and IC who agreed
to accept assignment of the application.
This policy applies to all new applications, competing renewal (formerly competing continuation ) applications, resubmission (formerly revised/amended ) applications, and revision (formerly competing supplemental ) applications. See NOT-OD-02-004, October 16, 2001.
Appendix Materials
NIH has published new limitations on grant application appendix materials to encourage applications to be as concise as possible while containing the information needed for expert scientific review. See http://grants.nih.gov/grants/guide/notice-files/NOT-OD-07-018.html.
Applicants must follow the specific instructions on Appendix materials as described in the SF424 (R&R) Application Guide (See http://grants.nih.gov/grants/funding/424/index.htm).
Do not use the Appendix to circumvent the page limitations of the Research Plan component. An application that does not observe the required page limitations may be delayed in the review process.
Note: While each section of the PHS398 Research Plan component needs to be uploaded separately as a PDF attachment, applicants are encouraged to construct the Research Plan component as a single document, separating sections into distinct PDF attachments just before uploading the files. This approach will enable applicants to monitor better formatting requirements such as page limits. All attachments must be provided to NIH in PDF format, filenames must be included with no spaces or special characters, and a .pdf extension must be used.
Foreign Applications (Non-domestic (non-U.S.) Entity)
Institutions and institutional policies, such as national health policies or income maintenance programs, can influence both the existence as well as the level of observed health disparities. Conducting research with only US data could limit the ability to consider the impact of national institutions and policies on disparities, because the same institutions cover all Americans. Cross-national comparisons may provide unique opportunities to examine the role of factors that vary at the national level. While this FOA focuses on disparities within the United States, research involving non-US or cross-national data or settings may meet the objectives of the FOA. Applicants using non-US data or settings must justify their research based on its applicability to identified health disparities in the United States.
Plan for Sharing Research Data
The precise content of the data-sharing plan will vary, depending on the data being collected and how the investigator is planning to share the data. Applicants who are planning to share data may wish to describe briefly the expected schedule for data sharing, the format of the final dataset, the documentation to be provided, whether or not any analytic tools also will be provided, whether or not a data-sharing agreement will be required and, if so, a brief description of such an agreement (including the criteria for deciding who can receive the data and whether or not any conditions will be placed on their use), and the mode of data sharing (e.g., under their own auspices by mailing a disk or posting data on their institutional or personal Web site, through a data archive or enclave). Investigators choosing to share under their own auspices may wish to enter into a data-sharing agreement. References to data sharing may also be appropriate in other sections of the application.
Applicants requesting more
than $500,000 in direct costs in any year of the proposed research must include
a plan for sharing research data in their application. The funding organization
will be responsible for monitoring the data sharing policy (http://grants.nih.gov/grants/policy/data_sharing).
The reasonableness of the
data sharing plan or the rationale for not sharing research data may be
assessed by the reviewers. However, reviewers will not factor the proposed data
sharing plan into the determination of scientific merit or the priority score.
Sharing Research Resources
NIH policy expects that grant
recipients make unique research resources readily available for research
purposes to qualified individuals within the scientific community after
publication (See the NIH Grants Policy Statement http://grants.nih.gov/grants/policy/nihgps_2003/NIHGPS_Part7.htm#_Toc54600131).
Investigators responding to this funding opportunity should include a sharing
research resources plan addressing how unique research resources will be shared
or explain why sharing is not possible.
The adequacy of the resources sharing plan and any
related data sharing plans will be considered by Program staff of the funding
organization when making recommendations about funding applications. The
effectiveness of the resource sharing will be evaluated as part of the
administrative review of each Non-Competing Grant Progress
Report (PHS 2590). See Section VI.3.,
Reporting.
Section V. Application Review Information
1. Criteria (Update: Enhanced review criteria have been issued for the evaluation of research applications received for potential FY2010 funding and thereafter - see NOT-OD-09-025).
Only the review criteria described below will be considered in the review process.
2.
Review and Selection Process
Applications submitted for this funding opportunity
will be assigned to the ICs on the basis of established PHS referral
guidelines.
Applications that
are complete will be evaluated for scientific and technical merit by an
appropriate peer review group convened by CSR in accordance with the review criteria stated below.
As part of the initial merit review, all applications will:
Applications submitted in response to this funding opportunity will compete for available funds with all other recommended applications. The following will be considered in making funding decisions:
The goals of NIH supported research are to advance our understanding of biological systems, to improve the control of disease, and to enhance health. In their written critiques, reviewers will be asked to comment on each of the following criteria in order to judge the likelihood that the proposed research will have a substantial impact on the pursuit of these goals. Each of these criteria will be addressed and considered in assigning the overall score, weighting them as appropriate for each application.
Note that an application does not need to be strong
in all categories to be judged likely to have major scientific impact and thus
deserve a high priority score. For example, an investigator may propose to
carry out important work that by its nature is not innovative but is essential
to move a field forward.
Significance: Does this study address an important problem? If the aims of the
application are achieved, how will scientific knowledge or clinical practice be
advanced? What will be the effect of these studies on the concepts, methods,
technologies, treatments, services, or preventative interventions that drive
this field?
Approach: Are the
conceptual or clinical framework, design, methods, and analyses adequately
developed, well integrated, well reasoned, and appropriate to the aims of the
project? Does the applicant acknowledge potential problem areas and consider
alternative tactics? For applications
designating multiple PDs/PIs, is the leadership approach, including the
designated roles and responsibilities, governance, and organizational
structure, consistent with and justified by the aims of the project and the
expertise of each of the PDs/PIs?
Innovation: Is the project original and innovative? For example: Does the project challenge existing paradigms or clinical practice; address an innovative hypothesis or critical barrier to progress in the field? Does the project develop or employ novel concepts, approaches, methodologies, tools, or technologies for this area
Investigators: Are the PD/PI(s)
and other key personnel appropriately trained and well suited to carry out this
work? Is the work proposed appropriate to the experience level of the principal
investigator and other researchers? Does the PD/PI(s) and investigative team
bring complementary and integrated expertise to the project (if applicable)?
Environment: Do(es) the
scientific environment(s) in which the work will be done contribute to the
probability of success? Do the proposed studies benefit from unique features of
the scientific environment, or subject populations, or employ useful
collaborative arrangements? Is there evidence of institutional support?
Foreign Research Entities or Data: Does the use of non-US data or settings inform efforts to understand or reduce health disparities in US populations? Are the analyses relevant to identified health disparities in the United States?
2.A. Additional Review Criteria
In addition to the above criteria, the following items will continue to be considered in the determination of scientific merit and the priority score:
Resubmission Applications (formerly revised/amended applications): Are the responses to comments from the previous scientific review group adequate? Are the improvements in the resubmission application appropriate?
Protection of Human Subjects
from Research Risk: The involvement of
human subjects and protections from research risk relating to their
participation in the proposed research will be assessed. See the Human
Subjects Sections of the PHS398 Research Plan component of the SF424
(R&R)..
Inclusion of Women, Minorities and Children in Research: The adequacy of
plans to include subjects from both genders, all racial and ethnic groups (and
subgroups), and children as appropriate for the scientific goals of the
research will be assessed. Plans for the recruitment and retention of subjects
will also be evaluated. See the Human Subjects Sections of the PHS398
Research Plan component of the SF424 (R&R)
Care and Use of Vertebrate Animals in Research: If vertebrate animals
are to be used in the project, the adequacy of the plans for their care and use
will be assessed. See the Other Research Plan Sections of the PHS398 Research
Plan component of the SF424 (R&R).
Biohazards: If materials or procedures are proposed that are potentially
hazardous to research personnel and/or the environment, determine if the
proposed protection is adequate.
2.B. Additional Review Considerations
Budget and Period of Support: The reasonableness of the proposed budget and the
appropriateness of the requested period of support in relation to the proposed
research may be assessed by the reviewers. The priority score should not be
affected by the evaluation of the budget.
Applications from Foreign Organizations: Whether the project presents special opportunities for furthering research programs through the use of unusual talent, resources, populations, or environmental conditions in other countries that are not readily available in the United States or that augment existing U.S. resources will be assessed.
2.C. Sharing Research Data
Data Sharing Plan: Applications requesting $500,000 or more in direct costs in any year are required to include a data-sharing plan. The reviewers may assess the reasonableness of the data sharing plan or the rationale for not sharing research data. However, reviewers will not factor the proposed data sharing plan into the determination of scientific merit or the priority score. The funding organization will be responsible for monitoring the data sharing policy. http://grants.nih.gov/grants/policy/data_sharing.
2.D. Sharing Research Resources
NIH policy expects that grant recipients make unique research resources readily available for research purposes to qualified individuals within the scientific community after publication (See the NIH Grants Policy Statement http://grants.nih.gov/grants/policy/nihgps_2003/NIHGPS_Part7.htm#_Toc54600131). Investigators responding to this funding opportunity should include a sharing research resources plan addressing how unique research resources will be shared or explain why sharing is not possible.
Program staff will be responsible for the administrative review of the plan for sharing research resources.
The adequacy of the resources
sharing plan and any related data sharing plans will be considered by Program
staff of the funding organization when making recommendations about funding
applications. The effectiveness of the resource sharing will be evaluated as
part of the administrative review of each Non-Competing Grant
Progress Report (PHS 2590), See Section VI.3.,
Reporting.
Model
Organism Sharing Plan: Reviewers are asked to assess the sharing plan in an administrative note. The sharing
plan itself should be discussed after the application is scored. Whether a
sharing plan is reasonable can be determined by the reviewers on a case-by-case
basis, taking into consideration the organism, the timeline, the applicant's
decision to distribute the resource or deposit it in a repository, and other
relevant considerations.
3.
Anticipated Announcement and Award Dates
Not
Applicable
Section
VI. Award Administration Information
1.
Award Notices
After the peer review of the application is completed, the PD/PI will be
able to access his or her Summary Statement (written critique) via the NIH eRA Commons.
If the application is under
consideration for funding, NIH will request "just-in-time"
information from the applicant. For details, applicants may refer to the NIH
Grants Policy Statement Part II: Terms and Conditions of NIH Grant Awards,
Subpart A: General.
A formal notification in the form of a Notice of Award
(NoA) will be provided to the applicant organization. The NoA signed by the
grants management officer is the authorizing document. Once all administrative
and programmatic issues have been resolved, the NoA will be generated via
E-mail notification from the awarding component to the grantee business
official.
Selection of an application for award is not an
authorization to begin performance. Any costs incurred before receipt of the
NoA are at the recipient's risk. These costs may be reimbursed only to the
extent considered allowable pre-award costs. See Section
IV.5., Funding Restrictions.
2. Administrative and National Policy Requirements
All NIH grant and cooperative agreement awards include the NIH Grants Policy Statement as part of the NoA. For these terms of award, see the NIH Grants Policy Statement Part II: Terms and Conditions of NIH Grant Awards, Subpart A: General and Part II: Terms and Conditions of NIH Grant Awards, Subpart B: Terms and Conditions for Specific Types of Grants, Grantees, and Activities.
When multiple years are involved, awardees will be required to submit the Non-Competing Grant Progress Report (PHS 2590) annually and financial statements as required in the NIH Grants Policy Statement.
We encourage your inquiries concerning this funding opportunity and welcome the opportunity to answer questions from potential applicants. Inquiries may fall into three areas: scientific/research, peer review, and financial or grants management issues:
1. Scientific/Research Contact(s):
For general information:
Ronald P. Abeles, Ph.D.
Office
of Behavioral and Social Sciences Research
National Institutes of Health
31
Center Drive
Building 31, Room B1C19
Bethesda, MD 20892-2027
Tel.: 301.496.7859
Fax: 301.435.8779
E-mail: abeles@nih.gov
Participating Components:
National Cancer Institute (NCI) http://www.nci.nih.gov/
Shobha
Srinivasan, Ph.D.
Health Disparities Research Coordinator
Division of Cancer Control and Population Sciences
National Cancer Institute
6130 Executive Blvd., Room 6126
Bethesda, MD 20892-7338
Tel.: 301.435.6614
Fax: 301.594.6787
E-mail: ss688k@nih.gov
National Center for Complementary and Alternative Medicine (NCCAM) http://nccam.nih.gov/
Catherine M.
Stoney, Ph.D.
National Center for Complementary & Alternative
Medicine
National Institutes of Health
6707 Democracy Blvd, Suite 401, MSC 5475
Bethesda, Maryland 20892-5475 (for express mail, use 20817)
Tel.: 301 402 1272
Fax: 301 480 3621
E-mail: stoneyc@mail.nih.gov
National Eye Institute (NEI) http://www.nei.nih.gov/
Dr. Jerome
R. Wujek
Research Resources Officer
Division of Extramural Research
National Eye Institute
Suite 1300
5635 Fishers Lane, MSC 9300
Bethesda, MD 20892-9300
Tel.: 301.451.2020
Fax: 301.402.0528
E-mail: wujekjer@nei.nih.gov
National Heart, Lung, and Blood Institute (NHLBI) http://www.nhlbi.nih.gov/index.htm
Charlotte
Pratt, Ph.D.
Program Director
Division of Prevention and Population Sciences
National Heart, Lung, and Blood Institute
6701 Rockledge Drive, Suite 10118, MSC 7936
Bethesda, MD 20892-7940
Tel.: 301.435.0382
Fax: 301.480.1773
E-mail: prattc@nhlbi.nih.gov
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) http://www.niams.nih.gov
Phil Tonkins, Dr. PH
Program Director
National Institute of Arthritis and Musculoskeletal and Skin Diseases/NIH
6701 Democracy Blvd, Suite 800
One Democracy Plaza
Bethesda, MD 20892-4870
Phone: 301- 594-4979
Fax: 301-480-1284
Email: tonkinsw2@mail.nih.gov
National Institute of Child Health and Human Development (NICHD) http://www.nichd.nih.gov/
Michael
Spittel, Ph.D.
Health Scientist Administrator
Demographic and Behavioral Sciences Branch
National Institute of Child Health & Human
Development
6100 Executive Boulevard, Rm. 8B07, MSC 7510
Bethesda, Maryland 20892-7510
Tel: 301.435.6983
Fax: 301 496-0962
Email: spittelm@mail.nih
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) http://www.niddk.nih.gov/
Lawrence
Agodoa, Ph.D
Director Office of Minority Health Research
Coordination
National Institute of Diabetes and Digestive and
Kidney Diseases
6706 Democracy Blvd., MSC 5454
Bethesda, MD 20892-5454
Tel.: 301.594.1932
Fax: 301.594.9358
E-mail: AgodoaL@extra.niddk.nih.gov
National Institute of Dental and Craniofacial Research (NIDCR)http://www.nidcr.nih.gov
Ruth Nowjack-Raymer, MPH, PhD
Director,
Health Disparities Research Program
National
Institute of Dental and Craniofacial Research
45 Center
Drive, Building 45, Room 4AS-43F
Bethesda, MD
20892-6401
Tel.: (301)
594-5394
FAX: (301)
480-8322
E-mail: Ruth.Nowjack-Raymer@nih.gov
National Institute of Environmental Health Sciences (NIEHS) http://www.niehs.nih.gov
Kimberly
Gray, Ph.D.
National Institute of Environmental Health Sciences
P.O. Box 12233 MD EC-21
111 T.W. Alexander Drive
Research Triangle Park , NC 27709
Tel.: 919.541.0293
Fax: 919.316.4606
E-mail: gray6@niehs.nih.gov
National Institute of General Medical Sciences (NIGMS) http://www.nigms.nih.gov/
Clifton Poodry, Ph.D.
Director, Division of Minority
Opportunities in Research
National Institute of General
Medical Sciences
45 Center Drive, MSC 6200
Building 45, Room 2AS37H
Bethesda, MD 20892-6200
Tel.: (301) 594-3900
Email: poodryc@nigms.nih.gov
National Institute of Allergy and Infectious Diseases (NIAID) http://www3.niaid.nih.gov
Roberta
Black, Ph.D.
Prevention Sciences Branch
National Institute of Allergy and
Infectious Diseases
6700B Rockledge Dr., MSC 7628
Bethesda, MD 20892-7628
Tel.: (301) 496-8199
E-mail: rblack@niaid.nih.gov
National Institute of Mental Health (NIMH) http://www.nimh.nih.gov
Robert A. Mays, Jr., Ph.D., MSW
Acting Chief, Mental Health
Disparities Research Program
Office for Special Populations
National Institute of Mental Health
6001 Executive Boulevard, Room
8125, MSC 9659
Bethesda, MD 20892-9659
Tel.: 301.443.2847
Fax: 301.443.8552
E-mail: Rmays@mail.nih.gov
National Institute of Neurological Disorders and Stroke (NINDS) http://www.ninds.nih.gov
Richard
Benson, M.D., Ph.D.
National Institute of Neurological Disorders and Stroke
Neuroscience Center, Room 2152
6001 Executive Blvd., MSC 9535
Bethesda, MD 20892-9535
Tel.: 301.496.2581
Fax: 301.594.5929
E-mail: bensonric@ninds.nih.gov
National Institute of Nursing Research (NINR) http://www.ninr.nih.gov/
Paul A.
Cotton, Ph.D., RD
Health Behavior and Minority
Health
National Institute of Nursing Research
6701 Democracy Blvd., Suite 710
One Democracy Plaza
Bethesda, MD 20892-4870
Tel.: 301.402.6423
Fax: 301.451.5647
E-mail: cottonp@mail.nih.gov
National Institute on Aging (NIA) http://www.nia.nih.gov
John W. R.
Phillips, PhD
Behavioral and Social Research Program
National Institute on Aging
7201 Wisconsin Avenue, Gateway 533
Bethesda, MD 20892
Tel.: 301.496.3138
Fax: 301.402.0051
E-mail: PhillipJ@mail.nih.gov
National Institute on Alcohol Abuse and Alcoholism (NIAAA) http://www.niaaa.nih.gov
Judith A.
Arroyo, Ph.D.
Division of Epidemiology and Prevention Research
National Institute on
Alcohol Abuse and Alcoholism
5635 Fishers Lane,
Room 2079
Bethesda, MD 20892-9034
Tel.: 301.402-0717
Fax: 301-443-8615
E-mail: jarroyo@mail.nih.gov
National Institute on Deafness and Communication Disorders (NIDCD) http://www.nidcd.nih.gov/
Howard J.
Hoffman, M.A.
Director, Epidemiology and Biostatistics Program
Translational Research Branch
Division of Scientific Programs
National Institute on Deafness and Other Communication Disorders
Executive Plaza South, Room 400A
6120 Executive Blvd., MSC 7180
Bethesda, MD 20892-7180
Tel.: 301.402.1843
Fax: 301.402.0390
E-mail: hoffmanh@nidcd.nih.gov
National Institute on Drug Abuse (NIDA)
http://www.nida.nih.gov
Dionne J.
Jones, Ph.D.
Services Research Branch
Division of Epidemiology
Services & Prevention Research
National Institute on Drug Abuse
6001 Executive Boulevard, Room
5185, MSC 9589
Bethesda, MD 20892
Tel.: 301-402-1984
Fax: 301-443-6815
E-mail: djones1@nida.nih.gov
National
Library of Medicine (NLM) http://www.nlm.nih.gov/
Hua-Chuan Sim, M.D
Program Officer
Division of Extramural Programs
National Library of Medicine
6705 Rockledge Drive, Suite 301
Bethesda, MD 20892-7968
Tel.: 301.594.4882
Fax: 301.402.2952
E-mail: simh@mail.nih.gov
Office of Public Health Research (OPHR/CDC) http://www.cdc.gov/od/science/PHResearch/
Juliana Cyril, Ph.D., MPH
Associate Director for Policy and Peer Review
Office of Public Health Research
Centers for Disease Control
and Prevention
1600 Clifton Road, MS D-72
Atlanta, GA 30333
Tel.: 404.639.4639
Fax: 404.639.4903
E-mail: jcyril@cdc.gov
2. Peer Review Contact(s):
Dr. Gabriel Fosu
Center for Scientific Review
National Institutes of Health
6701
Rockledge Drive MSC 7808
Bethesda,
MD 20892-7808
Tel.:
301.435.3562
E-mail: fosug@csr.nih.gov
3. Financial/Grants Management Contact(s):
National Center for Complementary and Alternative Medicine (NCCAM) http://nccam.nih.gov/
George Tucker
Grants Management Officer
National Center for Complementary and
Alternative Medicine
National Institutes of Health
6707 Democracy Blvd., Room 401, MSC 5475
Bethesda, MD 20892-5475
Tel.: 301.594.9102
E-mail: tuckerg@nccam.nih.gov
National
Cancer Institute (NCI) http://www.nci.nih.gov/
Crystal
Wolfrey
Chief, Cancer Control and Population Sciences Grants
Branch
Office of Grants Administration
National Cancer Institute
National Institutes of Health
6120 Executive Blvd., Suite 243
Bethesda, MD 20892
Tel:. 301.496.8634
Fax: 301.496.8601
E-mail: wolfreyc@mail.nih.gov
National Eye Institute (NEI) http://www.nei.nih.gov/
William W.
Darby
Grants Management Officer
Division of Extramural Research
National Eye Institute
National Institutes of Health
Suite 1300
5635 Fishers Lane, MSC 9300
Bethesda, MD 20892-9300
Tel.: 301.451.2020
Fax: 301.496.9997
E-mail: darbyw@nei.nih.gov
National Heart, Lung, and Blood Institute (NHLBI) http://www.nhlbi.nih.gov/index.htm
Robert L.
Tarwater
Senior Grants Management Specialist
Office of Grants Management
Division of Extramural Research Activities
National Heart, Lung, and
Blood Institute
6701 Rockledge Drive, Room 7150
Bethesda, Maryland 20892-7926
Tel.: 301.402.6090
Fax: 301.451.5462
E-mail: tarwater@nih.gov
National Institute of Allergy and
Infectious Diseases (NIAID)
http://www.niaid.nih.gov
Christy
Leake
Grants Management Specialist
DHHS/NIAID/DEA/GMP
6700-B Rockledge Dr. Room 2242
Bethesda, MD 20892
Tel.: 301.402.5937
Fax: 301.493.0597
E-mail: cleake@niaid.nih.gov
National Institute of Arthritis
and Musculoskeletal and Skin Diseases (NIAMS) http://www.niams.nih.gov
Gail
Hamilton
Grants Management Specialist
National Institute of
Arthritis and Musculoskeletal and Skin Diseases
6701 Democracy Boulevard, Suite 800
Bethesda, MD 20892
Tel.: 301. 594.3506
Fax: 301.480.5450
E-mail: hamiltog@mail.nih.gov
National Institute on Aging (NIA) http://www.nia.nih.gov
John Bladen
Grants Management Specialist
The National Institute on Aging
Grants and Contracts
Management Office
Gateway Bl vd., Suite. 2N212
7201 Wisconsin Avenue
Bethesda, MD 20902
Tel: 301.496.1472
Fax: 301.402.3672
E-mail: bladenj@nia.nih.gov
National
Institute of Mental Health (NIMH) http://www.nimh.nih.gov
Rebecca
Claycamp, CRA
Division of Extramural
Activities
National Institute of Mental Health
6001 Executive Boulevard, Room 6122, MSC 9605
Bethesda, MD 20892-9605
Tel.: 301.443.2811
Fax: 301.443.6885
E-mail: rc253d@nih.gov
National Institute of Child Health and Human Development (NICHD) http://www.nichd.nih.gov/
Cecilia E.
Bruce
Supervisory Grants Management Specialist (Team
Leader)
National Institute of Child Health and Human
Development
6100 Executive Blvd - Room 8A17L
Rockville, MD 20852
Tel.: 301.496.1304
Fax: 301.480.4782
E-mail: brucec@mail.nih.gov
National Institute of Nursing Research (NINR) http://www.ninr.nih.gov/
Brian Albertini
Chief, Grants Management
National Institute of Nursing Research
6701 Democracy Blvd., Suite 710
One Democracy Plaza
Bethesda, MD 20892-4870
Tel.: 301.594.6869
Fax: 301.402.4502
E-mail: albertib@mail.nih.gov
National Institute on Alcohol Abuse and Alcoholism (NIAAA) http://www.niaaa.nih.gov/
Judy Fox
Chief, Grants Management Branch
National Institute on Alcohol Abuse and Alcoholism
5635 Fishers Lane,
Room 3023
Bethesda, MD 20892-9034
Tel.: 301.443.4704
Fax: 301.443.3891
E-mail: jfox@mail.nih.gov
National Institute on Deafness
and Communication Disorders (NIDCD) http://www.nidcd.nih.gov/
Chris Myers
Grants Management Branch
National Institute on Deafness and Other
Communication Disorders
Executive Plaza South, Room 400B
6120 Executive Blvd., MSC 7180
Bethesda, MD 20892-7180
Tel.: 301.402.0909
Fax: 301.402.1798
E-mail: myersc@nidcd.nih.gov
National
Institute on Drug Abuse (NIDA) http://www.nida.nih.gov
Edith Davis
Grants Management Branch
National Institute on Drug Abuse,
6101 Executive Boulevard, Room 270, MSC 8403
Rockville, MD 20852
Tel.: 301-443-6710
Fax: 301- 594-6849
E-mail: edavis1@nida.nih.gov
National Institute of Diabetes and Digestive and Kidney
Diseases (NIDDK) http://www.niddk.nih.gov/
Robert Pike
Chief, Grants Management Officer
National Institute of Diabetes & Digestive &
Kidney Diseases
National Institutes of Health
2 Democracy Plaza, MSC 5450
6707 Democracy Blvd., Room 731
Bethesda, MD 20892-5450
Tel: 301.594.8854
Fax: 301.594.9523
E-mail: pikera@niddk.nih.gov
National Institute of General Medical Sciences (NIGMS) http://www.nigms.nih.gov/
Antoinette Holland
Supervisory Grants Management
Officer
National Institute of General Medical Sciences
MSC 6200 45 Center Drive
Bethesda, MD 20892-6200
Tel.: 301.594.5132
Fax: 301.480.2554
E-mail: HOLLANDA@nigms.nih.gov
National Institute of Dental and
Craniofacial Research (NIDCR)
http://www.nidcr.nih.gov
Mary Daley
Chief Grants Management Officer
National Institute of Dental and Craniofacial
Research
45 Center Drive, Building 45, Room 4AN-44B
Bethesda, MD 20892-6402
Tel.: (301) 594-4808
FAX: (301) 480-3562
E-mail: md74u@nih.gov
National Institute of
Environmental Health Sciences (NIEHS)
http://www.niehs.nih.gov
Donald Ellis
Grants Management Specialist
NIEHS Grants Management Branch
P.O. Box 12233, MD/EC-22
Research Triangle Park, NC 27709
Tel.: (919) 541-1874
E-mail: donaldellis@niehs.nih.gov
National Institute of Neurological Disorders and Stroke (NINDS) http://www.ninds.nih.gov
Gavin Wilkom
Grants Management Specialist
National Institute of Neurological Disorders and
Stroke
6001 Executive Blvd., MSC 9537
Bethesda, MD 20892-9537
Tel.: 301.496.7480
Fax: 301.451.5635
E-mail: wilkomg@ninds.nih.gov
National Library of Medicine
(NLM) http://www.nlm.nih.gov/
Arnita Miles
Grants Management Specialist
Division of Extramural
Programs
National Library of Medicine
6705 Rockledge Drive, Suite 301
Bethesda, MD 20892-7968
Tel.: 301.496.4221
Fax: 301.402.0421
E-mail: milesar@mail.nih.gov
Office of Public Health Research (OPHR/CDC) http://www.cdc.gov/od/science/PHResearch/
Mattie
Jackson, Grants Management Specialist
Procurement and Grants Office
Centers for Disease
Control and Prevention (CDC)
2920 Brandywine Road, Mailstop K-14
Atlanta, GA 30341-4146
Tel.: 770.488.2696
Fax: 770.488.2670
E-mail: mij3@CDC.GOV
Section VIII. Other Information
Required Federal Citations
Use of Animals in Research:
Recipients of PHS support for activities involving
live, vertebrate animals must comply with PHS Policy on Humane Care and Use of
Laboratory Animals (http://grants.nih.gov/grants/olaw/references/PHSPolicyLabAnimals.pdf)
as mandated by the Health Research Extension Act of 1985 (http://grants.nih.gov/grants/olaw/references/hrea1985.htm),
and the USDA Animal Welfare Regulations (http://www.nal.usda.gov/awic/legislat/usdaleg1.htm)
as applicable.
Human Subjects Protection:
Federal regulations (45 CFR 46) require that
applications and proposals involving human subjects must be evaluated with
reference to the risks to the subjects, the adequacy of protection against
these risks, the potential benefits of the research to the subjects and others,
and the importance of the knowledge gained or to be gained (http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.htm).
Data and Safety Monitoring Plan:
Data and safety monitoring is required for all types
of clinical trials, including physiologic toxicity and dose-finding studies
(Phase I); efficacy studies (Phase II); efficacy, effectiveness and comparative
trials (Phase III). Monitoring should be commensurate with risk. The
establishment of data and safety monitoring boards (DSMBs) is required for multi-site
clinical trials involving interventions that entail potential risks to the
participants ( NIH Policy for Data and Safety Monitoring, NIH Guide for Grants and Contracts, http://grants.nih.gov/grants/guide/notice-files/not98-084.html).
Sharing Research Data:
Investigators submitting an NIH application seeking
$500,000 or more in direct costs in any single year are expected to include a
plan for data sharing or state why this is not possible (http://grants.nih.gov/grants/policy/data_sharing).
Investigators should seek guidance from their
institutions, on issues related to institutional policies and local IRB rules,
as well as local, State and Federal laws and regulations, including the Privacy
Rule. Reviewers will consider the data sharing plan but will not factor the
plan into the determination of the scientific merit or the priority score.
Access to Research Data through
the Freedom of Information Act:
The Office of Management and Budget (OMB) Circular
A-110 has been revised to provide access to research data through the Freedom
of Information Act (FOIA) under some circumstances. Data that are (1) first produced
in a project that is supported in whole or in part with Federal funds and (2)
cited publicly and officially by a Federal agency in support of an action that
has the force and effect of law (i.e., a regulation) may be accessed through
FOIA. It is important for applicants to understand the basic scope of this
amendment. NIH has provided guidance at http://grants.nih.gov/grants/policy/a110/a110_guidance_dec1999.htm.
Applicants may wish to place data collected under this funding opportunity in a
public archive, which can provide protections for the data and manage the
distribution for an indefinite period of time. If so, the application should
include a description of the archiving plan in the study design and include
information about this in the budget justification section of the application.
In addition, applicants should think about how to structure informed consent
statements and other human subjects procedures given the potential for wider
use of data collected under this award.
Sharing of Model Organisms:
NIH is committed to support efforts that encourage
sharing of important research resources including the sharing of model
organisms for biomedical research (see http://grants.nih.gov/grants/policy/model_organism/index.htm).
At the same time the NIH recognizes the rights of grantees and contractors to
elect and retain title to subject inventions developed with Federal funding
pursuant to the Bayh Dole Act (see the NIH
Grants Policy Statement. Beginning October 1, 2004, all investigators
submitting an NIH application or contract proposal are expected to include in
the application/proposal a description of a specific plan for sharing and
distributing unique model organism research resources generated using NIH
funding or state why such sharing is restricted or not possible. This will
permit other researchers to benefit from the resources developed with public
funding. The inclusion of a model organism sharing plan is not subject to a
cost threshold in any year and is expected to be included in all applications
where the development of model organisms is anticipated.
Inclusion of Women And Minorities in Clinical
Research:
It is the policy of the NIH that women and members of
minority groups and their sub-populations must be included in all NIH-supported
clinical research projects unless a clear and compelling justification is
provided indicating that inclusion is inappropriate with respect to the health
of the subjects or the purpose of the research. This policy results from the
NIH Revitalization Act of 1993 (Section 492B of Public Law 103-43). All
investigators proposing clinical research should read the "NIH Guidelines for Inclusion of Women and Minorities as Subjects in Clinical Research (http://grants.nih.gov/grants/guide/notice-files/NOT-OD-02-001.html);
a complete copy of the updated Guidelines is available at http://grants.nih.gov/grants/funding/women_min/guidelines_amended_10_2001.htm.
The amended policy incorporates: the use of an NIH definition of clinical
research; updated racial and ethnic categories in compliance with the new OMB
standards; clarification of language governing NIH-defined Phase III clinical
trials consistent with the SF424 (R&R) application; and updated roles and
responsibilities of NIH staff and the extramural community. The policy
continues to require for all NIH-defined Phase III clinical trials that: a) all
applications or proposals and/or protocols must provide a description of plans
to conduct analyses, as appropriate, to address differences by sex/gender
and/or racial/ethnic groups, including subgroups if applicable; and b)
investigators must report annual accrual and progress in conducting analyses,
as appropriate, by sex/gender and/or racial/ethnic group differences.
Inclusion of Children as Participants in Clinical
Research:
The NIH maintains a policy that children (i.e.,
individuals under the age of 21) must be included in all clinical research,
conducted or supported by the NIH, unless there are scientific and ethical
reasons not to include them.
All investigators proposing research involving human
subjects should read the "NIH Policy and Guidelines" on the inclusion
of children as participants in research involving human subjects (http://grants.nih.gov/grants/funding/children/children.htm).
Required Education on the Protection of Human
Subject Participants:
NIH policy requires education on the protection of
human subject participants for all investigators submitting NIH applications
for research involving human subjects and individuals designated as key
personnel. The policy is available at http://grants.nih.gov/grants/guide/notice-files/NOT-OD-00-039.html.
Human Embryonic Stem Cells (hESC):
Criteria for federal funding of research on hESCs can
be found at http://stemcells.nih.gov/index.asp and at http://grants.nih.gov/grants/guide/notice-files/NOT-OD-02-005.html.
Only research using hESC lines that are registered in the NIH Human Embryonic
Stem Cell Registry will be eligible for Federal funding (http://escr.nih.gov/). It is the responsibility
of the applicant to provide in the project description and elsewhere in the
application as appropriate, the official NIH identifier(s) for the hESC line(s)
to be used in the proposed research. Applications that do not provide this
information will be returned without review.
NIH Public Access Policy:
NIH-funded investigators are requested to submit to
the NIH manuscript submission (NIHMS) system (http://www.nihms.nih.gov/) at PubMed
Central (PMC) an electronic version of the author's final manuscript upon
acceptance for publication, resulting from research supported in whole or in
part with direct costs from NIH. The author's final manuscript is defined as
the final version accepted for journal publication, and includes all modifications
from the publishing peer review process.
NIH is requesting that authors submit manuscripts
resulting from 1) currently funded NIH research projects or 2) previously
supported NIH research projects if they are accepted for publication on or
after May 2, 2005. The NIH Public Access Policy applies to all research grant
and career development award mechanisms, cooperative agreements, contracts,
Institutional and Individual Ruth L. Kirschstein National Research Service
Awards, as well as NIH intramural research studies. The Policy applies to
peer-reviewed, original research publications that have been supported in whole
or in part with direct costs from NIH, but it does not apply to book chapters,
editorials, reviews, or conference proceedings. Publications resulting from
non-NIH-supported research projects should not be submitted.
For more information about the Policy or the
submission process, please visit the NIH Public Access Policy Web site at http://publicaccess.nih.gov// and view
the Policy or other Resources and Tools, including the Authors' Manual.
Standards for Privacy of Individually Identifiable
Health Information:
The Department of Health and Human Services (HHS)
issued final modification to the "Standards for Privacy of Individually
Identifiable Health Information", the "Privacy Rule", on August
14, 2002. The Privacy Rule is a federal regulation under the Health Insurance
Portability and Accountability Act (HIPAA) of 1996 that governs the protection
of individually identifiable health information, and is administered and
enforced by the HHS Office for Civil Rights (OCR).
Decisions about applicability and implementation of
the Privacy Rule reside with the researcher and his/her institution. The OCR
website (http://www.hhs.gov/ocr/)
provides information on the Privacy Rule, including a complete Regulation Text
and a set of decision tools on "Am I a covered entity?" Information
on the impact of the HIPAA Privacy Rule on NIH processes involving the review,
funding, and progress monitoring of grants, cooperative agreements, and
research contracts can be found at http://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-025.html.
URLs in NIH Grant Applications or Appendices:
All applications and proposals for NIH
funding must be self-contained within specified page limitations. For
publications listed in the appendix and/or Progress report, Internet addresses
(URLs) or PubMed Central (PMC) submission identification numbers must be used
for publicly accessible on-line journal articles. Publicly accessible
on-line journal articles or PMC articles/manuscripts accepted for publication
that are directly relevant to the project may be included only as URLs or PMC submission identification numbers accompanying the full reference
in either the Bibliography & References Cited section, the Progress Report
Publication List section, or the Biographical Sketch section of the NIH grant
application. A URL or PMC submission identification number citation may be
repeated in each of these sections as appropriate. There is no limit to the number
of URLs or PMC submission identification numbers that can be cited.
Healthy People 2010:
The Public Health Service (PHS) is committed to
achieving the health promotion and disease/disability prevention objectives of
"Healthy People 2010," a PHS-led national activity for setting
priority areas. This FOA is related to one or more of the priority areas.
Potential applicants may obtain a copy of "Healthy People 2010" at http://www.health.gov/healthypeople.
Authority and Regulations:
This program is described in
the Catalog of Federal Domestic Assistance at http://www.cfda.gov/ and is not subject to the intergovernmental review requirements of Executive
Order 12372 or Health Systems Agency review. Awards are made under the
authorization of Sections 301 and 405 of the Public Health Service Act as
amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and
45 CFR Parts 74 and 92. All awards are subject to the terms and conditions,
cost principles, and other considerations described in the NIH Grants
Policy Statement.
The PHS strongly encourages all grant recipients to
provide a smoke-free workplace and discourage the use of all tobacco products.
In addition, Public Law 103-227, the Pro-Children Act of 1994, prohibits
smoking in certain facilities (or in some cases, any portion of a facility) in
which regular or routine education, library, day care, health care, or early
childhood development services are provided to children. This is consistent
with the PHS mission to protect and advance the physical and mental health of
the American people.
Loan Repayment Programs:
NIH encourages applications for educational loan
repayment from qualified health professionals who have made a commitment to
pursue a research career involving clinical, pediatric, contraception,
infertility, and health disparities related areas. The LRP is an important
component of NIH's efforts to recruit and retain the next generation of
researchers by providing the means for developing a research career unfettered
by the burden of student loan debt. Note that an NIH grant is not required for
eligibility and concurrent career award and LRP applications are encouraged.
The periods of career award and LRP award may overlap providing the LRP
recipient with the required commitment of time and effort, as LRP awardees must
commit at least 50% of their time (at least 20 hours per week based on a 40
hour week) for two years to the research. For further information, please see: http://www.lrp.nih.gov/.
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
| ||||||
Department of Health and Human Services (HHS) |
||||||
NIH... Turning Discovery Into Health® |